West Family Investments Inc. Invests $551,000 in The Cooper Companies, Inc. $COO

West Family Investments Inc. purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, HoldingsChannel.com reports. The institutional investor purchased 7,690 shares of the medical device company’s stock, valued at approximately $551,000.

Several other institutional investors also recently modified their holdings of COO. Avalon Trust Co bought a new stake in Cooper Companies in the 2nd quarter worth about $25,000. Root Financial Partners LLC lifted its stake in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. boosted its holdings in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares during the last quarter. Elevation Wealth Partners LLC boosted its holdings in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after acquiring an additional 375 shares during the last quarter. Finally, Continuum Advisory LLC purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at about $30,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

COO has been the topic of a number of research analyst reports. Wells Fargo & Company restated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Citigroup reaffirmed a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. JPMorgan Chase & Co. decreased their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Cooper Companies in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $81.64.

Cooper Companies Trading Down 2.7%

Shares of COO stock opened at $67.69 on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a fifty day simple moving average of $72.59 and a two-hundred day simple moving average of $70.17. The firm has a market capitalization of $13.20 billion, a PE ratio of 57.36, a PEG ratio of 1.82 and a beta of 0.82. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.